Protection against Lipopolysaccharide-Induced Death by Fluoroquinolones

AUTOR(ES)

Khan, Anis A.

FONTE

American Society for Microbiology

RESUMO

Because fluoroquinolones have an immunomodulatory effect on cytokine production by lipopolysaccharide (LPS)-treated human monocytes, we examined the effect of fluoroquinolones on the survival of mice injected with a lethal dose of LPS. Trovafloxacin (100 mg/kg), ciprofloxacin (250 mg/kg), and tosufloxacin (100 mg/kg) protected 75% (P = 0.0001), 25% (P = 0.002), and 50% (P = 0.002), respectively, of mice against death. The fluoroquinolones significantly reduced serum levels of interleukin-6 and tumor necrosis factor alpha in LPS-treated mice. The protective effects of fluoroquinolones in LPS-induced shock in mice may also occur in humans.

Documentos Relacionados

• Protection from Lipopolysaccharide-induced Lung Injury by Augmentation of Airway S-Nitrosothiols
• Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion.
• Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptides.
• Galantamine protects against lipopolysaccharide-induced acute lung injury in rats
• Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.